Literature DB >> 7812697

Smoking of hand-rolled cigarettes as a risk factor for small cell lung cancer in men: a case-control study from Uruguay.

E De Stéfani1, L Fierro, M T Larrinaga, J C Balbi, A Ronco, M Mendilaharsu.   

Abstract

During the time period January 1989-December 1992, a case-control study involving 476 cases of lung cancer and 561 controls was carried out at the Instituto Nacional de Oncología, Montevideo, Uruguay, in order to analyze the patterns of risk of the different cell types of lung cancer, associated with smoking manufactured and hand-rolled cigarettes. Lifelong smokers of hand-rolled cigarettes displayed a non-significant 30% increased risk, compared with smokers of commercial cigarettes, for all types of lung cancer combined. The analysis for cell-type disclosed a fourfold increase in the risk of small cell lung carcinoma associated with lifelong smoking of hand-rolled products. The possibilities of a chance finding and of misclassification of the disease appears to be an unlikely explanation of this strong and rather specific association.

Entities:  

Mesh:

Year:  1994        PMID: 7812697     DOI: 10.1016/0169-5002(94)90539-8

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  3 in total

Review 1.  Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer.

Authors:  Peter N Lee; Barbara A Forey; Katharine J Coombs
Journal:  BMC Cancer       Date:  2012-09-03       Impact factor: 4.430

2.  The impact of smoking habits on lung cancer risk: 28 years' observation of 26,000 Norwegian men and women.

Authors:  A Engeland; T Haldorsen; A Andersen; S Tretli
Journal:  Cancer Causes Control       Date:  1996-05       Impact factor: 2.506

3.  Roll-your-own cigarettes in Europe: use, weight and implications for fiscal policies.

Authors:  Silvano Gallus; Alessandra Lugo; Simone Ghislandi; Carlo La Vecchia; Anna B Gilmore
Journal:  Eur J Cancer Prev       Date:  2014-05       Impact factor: 2.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.